pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,876 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 29 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: device pma×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07431372: Validation of the Shared Happiness Index in Multidisciplinary Primary Care Practices ( Be aPi )

    Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: . Conditions: Well Being

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05916495: An Evaluation of Remote Care (Questionnaire+Hybrid) in Patients Who Are Post-lung Transplant

    Sponsor: University of Manchester. Phase: NA. Conditions: Lung Transplant; Complications

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06526195: Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

    Sponsor: Abbott Medical Devices. Phase: NA. Conditions: Heart Failure, Heart Diseases, Cardiovascular Diseases, Pulmonary Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07248839: A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

    Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Volunteers, Hepatic Impairment

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02117375: EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients

    Sponsor: Rennes University Hospital. Phase: NA. Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05332275: A Media Parenting Prevention Intervention

    Sponsor: University of Florida. Phase: NA. Conditions: Substance Related Problem

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04138277: A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

    Sponsor: Amicus Therapeutics. Phase: PHASE3. Conditions: Pompe Disease (Late-onset)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03910075: Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)

    Sponsor: Virginia Polytechnic Institute and State University. Phase: PHASE3. Conditions: Perinatal Stroke, Hemiparesis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03998501: fMRI to Examine the Effect of CBTm to Increase Resiliency for PTSD

    Sponsor: University of Manitoba. Phase: NA. Conditions: Stress Disorders, Post-Traumatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05923801: Changing Tactics? Optimizing ECT in Difficult-to-treat Depression

    Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: NA. Conditions: Depression

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06054230: Genomic Sequencing for Evaluation of Fetal Structural Anomalies

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Fetal Structural Anomalies

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05747430: SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)

    Sponsor: iRenix Medical, Inc.. Phase: PHASE2. Conditions: Retinal Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07465328: Studying the Impairment of Stroke and Sarcopenia Patients Using Maximum Voluntary Contractions of the Leg Joints.

    Sponsor: Vrije Universiteit Brussel. Phase: NA. Conditions: Sarcopenia, Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02792465: A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors

    Sponsor: University Health Network, Toronto. Phase: PHASE1. Conditions: Advanced Solid Cancers, Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07182565: Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma

    Sponsor: West China Hospital. Phase: PHASE1. Conditions: Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07216365: Caffeine Optimization for Oxygen Saturation Index in ELBW Infants

    Sponsor: University of Rochester. Phase: PHASE2. Conditions: Neonatal Apnea, Infants

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05167565: Longitudinal Development of Behavior and Its Underlying Neural Correlates in Human Infants

    Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05345171: Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency

    Sponsor: Ultragenyx Pharmaceutical Inc. Phase: PHASE3. Conditions: OTC Deficiency

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05258071: A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)

    Sponsor: Integrative Research Laboratories AB. Phase: PHASE2. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05203471: Crossing the Divide: Piloting Integrated Care to Reduce Amputations Among Rural Patients With Diabetic Foot Ulcers

    Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Diabetic Foot, Diabetic Ulcer of Left Foot, Diabetic Ulcer of Right Foot, Amputation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07025083: Adaptation of the Family Check-Up Online

    Sponsor: University of Oregon. Phase: NA. Conditions: Substance Use (Drugs, Alcohol)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07634341: Clinical and Radiographic Evaluation of Doxycycline and Atorvastatin Loaded Chitosan Nanoparticles as an Adjunctive to Scaling and Root Planning in the Management of Chronic Periodontitis. A Randomized Controlled Clinical Trial.

    Sponsor: Fayoum University. Phase: PHASE4. Conditions: Chronic Periodontitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02444741: Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Malignant Solid Neoplasm, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04774354: POSSUM, P-POSSUM, Clinical Frailty Scale, Clinical Frailty Scale and Charlson's Comorbidity Index in Abdominal Surgery.

    Sponsor: Ángel Becerra-Bolaños, MD PhD. Phase: . Conditions: Postoperative Complications

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06458205: Impact of Multi-Component Interventions on High-Risk COPD Smokers

    Sponsor: Peking Union Medical College. Phase: NA. Conditions: Multimorbidity, Tobacco Use Cessation, Smoking Reduction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07278466: The COMParing App Support Strategies Study

    Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Depression, Anxiety

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07512466: Evaluation of Endoscopic Management of Sinonasal Tumors In Difficult Anatomical Locations

    Sponsor: Assiut University. Phase: NA. Conditions: Nasal Cavity and Paranasal Sinus Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06172166: Transdisciplinary Care for Young Adults With Type 1 Diabetes

    Sponsor: Nemours Children's Clinic. Phase: NA. Conditions: Type 1 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05744856: A Co-created Self-care and Informal Support Intervention Study Among Women With GDM in Vietnam

    Sponsor: Thai Binh University of Medicine and Pharmacy. Phase: NA. Conditions: GDM

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04647422: Social Cognition and Executive Functions in Alcohol Use Disorders - Transverse Study

    Sponsor: CHU de Reims. Phase: NA. Conditions: Alcohol Use Disorder

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07589751: Biomaterials Exposed to Oral Environment: Which One is the Appropriate Option?

    Sponsor: Pontificia Universidade Católica do Rio Grande do Sul. Phase: NA. Conditions: Tooth Extraction Site Healing, Alveolar Ridge Preservation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07517029: Gut Microbiome in Patients With Post-infectious Irritable Bowel Syndrome

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: IBS - Irritable Bowel Syndrome, Post Infection Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05966129: A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Acute Pain Trial)

    Sponsor: Duke University. Phase: NA. Conditions: Acute Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07196631: Comparison of Liposomal Bupivacaine Versus Ropivacaine in Alleviating Rebound Pain

    Sponsor: Liu Jiuhong. Phase: PHASE4. Conditions: Rebound Pain, Liposomal Bupivacaine

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07255937: PMCF Study of Debridement Pad

    Sponsor: Advanced Medical Solutions Ltd.. Phase: NA. Conditions: Diabetic Ulcers, Venous Leg Ulcer, Arterial Leg Ulcer, Pressure Ulcer, Postoperative Wound Healing, Traumatic Wounds, Surgical Wounds, Burns and Scalds

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT04973345: Terbutaline Sulfate in Adults With Asthma

    Sponsor: Kanecia Obie Zimmerman. Phase: PHASE2. Conditions: Asthma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07326072: The Study of ENB With Ultra-thin Cryobiopsy in the Diagnosis of Peripheral Pulmonary Nodules

    Sponsor: Beijing Chao Yang Hospital. Phase: NA. Conditions: Diagnosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05353257: A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

    Sponsor: Shanghai Henlius Biotech. Phase: PHASE3. Conditions: Limited-Stage Small Cell Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07547657: Implementation Guided by aN Iterative, adapTivE Strategy - Induction of Labor

    Sponsor: University of Michigan. Phase: NA. Conditions: Birth; Induced

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06280157: A Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers

    Sponsor: Minervax ApS. Phase: . Conditions: Group B Streptococcus Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07691801: Study on the Application of Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Aldosterone and Renin Activity in the Diagnosis of Primary Aldosteronism by Captopril Test

    Sponsor: Peking Union Medical College Hospital. Phase: . Conditions: Primary Aldosteronism

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06307301: Study in ALS With Abatacept & IL-2

    Sponsor: The Methodist Hospital Research Institute. Phase: PHASE1. Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT07219381: Holistic Medicine Treatment of Uterine Fibroids-Adults

    Sponsor: Virtual Tribunal Monastery. Phase: NA. Conditions: Uterine Fibroids - 1St Diagnosis, Uterine Fibroids Affecting Pregnancy, Uterine Fibroid Degenerated

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04498481: TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

    Sponsor: Pfizer. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07527481: Nortriptyline and the Risk of Serious Adverse Events

    Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Phase: . Conditions: Chronic Kidney Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05934019: Efficacy of a Transdiagnostic Online Prevention Approach in Adolescents (EMPATIA)

    Sponsor: University of Bern. Phase: NA. Conditions: Mental Health Issue, Transdiagnostic Mechanisms, Adolescent Psychology, Prevention, Online Intervention, Psychological Intervention, Mental Disorder in Adolescence, Subclinical

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07456319: Sustainable Insect-based Protein Supplement in the Elderly: a Pilot Study

    Sponsor: Universitat Oberta de Catalunya. Phase: NA. Conditions: Aging, Nutrition, Sustainable Diets, Cardiometabolic Health

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05363319: An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe

    Sponsor: Regeneron Pharmaceuticals. Phase: . Conditions: Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07380230: Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients

    Sponsor: LI FENG. Phase: NA. Conditions: Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM), Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07321730: Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian Cancer

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Ovarian Cancer

    full page →ctgov ↗
    ← prev
    page 76 of 98
    next →